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Abstract
Background: The murine ghrelin gene (Ghrl), originally sequenced from stomach tissue, contains
five exons and a single transcription start site in a short, 19 bp first exon (exon 0). We recently
isolated several novel first exons of the human ghrelin gene and found evidence of a complex
transcriptional repertoire. In this report, we examined the 5' exons of the murine ghrelin
orthologue in a range of tissues using 5' RACE.
Findings: 5' RACE revealed two transcription start sites (TSSs) in exon 0 and four TSSs in intron
0, which correspond to 5' extensions of exon 1. Using quantitative, real-time RT-PCR (qRT-PCR),
we demonstrated that extended exon 1 containing Ghrl transcripts are largely confined to the
spleen, adrenal gland, stomach, and skin.
Conclusion: We demonstrate that multiple transcription start sites are present in exon 0 and an
extended exon 1 of the murine ghrelin gene, similar to the proximal first exon organisation of its
human orthologue. The identification of several transcription start sites in intron 0 of mouse ghrelin
(resulting in an extension of exon 1) raises the possibility that developmental-, cell- and tissue-
specific Ghrl mRNA species are created by employing alternative promoters and further studies of
the murine ghrelin gene are warranted.
Background
Ghrelin is a 28 amino acid peptide, predominantly
expressed in the stomach, and is cleaved from a 117
amino acid preprohormone, preproghrelin [1]. Our previ-
ously published comparative genomics analysis suggested
that the mouse and human first exon architecture is con-
served [2] and we demonstrated that the human ghrelin
gene (GHRL) contains several untranslated first exons that
may play a role in regulating ghrelin gene translation [2].
In this study we investigate the existence of novel exons of
the murine ghrelin orthologue (Ghrl).
Findings
Identification of a novel first exon and transcription start 
sites of the murine ghrelin gene
It has previously been reported that the mouse ghrelin
gene consists of four coding exons (exons 1 to 4) and a
short, non-coding 19 bp first exon [3], which we have
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termed exon 0. To determine if additional first exon and
transcription start sites are present, 5' RACE (rapid ampli-
fication of 5' complementary DNA ends) was performed
with exon 1-specific reverse primers and a RACE-ready
panel of anchored cDNA libraries derived from 24 mouse
tissues (OriGene, Rockville, MD). A list of exons and
exon-intron boundaries of the ghrelin locus derived-tran-
scripts identified in this and previous studies is given in
[Additional file 1].
Sequencing of clones from the murine stomach, lung, and
9.5-day embryo revealed two transcription start sites (TSS)
in exon 0 (Fig. 1), which are 48 bp [GenBank: FJ355944]
and 19 bp [GenBank:FJ355945] in size. The 19 bp exon 0
(exon 0a) is identical to a sequence previously reported in
the mouse stomach [3], while the 48 bp exon 0 (exon 0b)
is flanked by a CAGE tag starting site (CTSS) (Fig. 1).
CTSSs are obtained by large-scale sequencing of concate-
mers derived from the 5' ends of capped mRNA and indi-
cate the transcription start site [4].
In our earlier report we noted that a region immediately
upstream of exon 1 (intron 0) of the ghrelin gene is highly
conserved between the mouse and human orthologues
[2]. This suggested that transcription of the murine ghre-
lin gene could also be initiated from within intron 0. We
isolated murine 5' RACE clones that contained extended
exon 1 sequence (Fig. 1). These clones were isolated from
9.5-day embryo, 12.5-day embryo, adult lung, and adult
adrenal gland [GenBank:FJ355940–FJ355943] and corre-
spond to four transcription start sites within intron 0 of
the mouse ghrelin gene. Interestingly, an extended exon 1
that contains 61 bp of intron 0 sequence (exon 1e) is
present in a conserved region immediately upstream of
exon 1 [2] and is flanked by the previously reported
human transcription start site [5] (Fig. 2).
In a recent study we also identified a human ghrelin exon
(exon -1) 2.6 kb upstream of the preproghrelin translation
start site in exon 1 [2]. These human exon 1-derived ghre-
lin transcripts contain a putative secretion signal peptide,
which is not present in the rodent sequence, and may give
rise to novel peptides [2]. Mouse ghrelin appears to lack
exon -1, as we have been unable to identify murine exon -
1 ghrelin sequence using 5' RACE and RT-PCR (data not
shown). Promoter sequences are known to evolve rapidly
and show a high rate of sequence turnover [6,7]; thus, it is
not surprising that the region corresponding to murine
exon -1 is not a functional ghrelin gene exon in the
mouse.
The extended exon 1 of Ghrl is transcribed and gives rise 
to full-length preproghrelin transcripts
While 5' RACE data [5] and sequence from a full-length
cDNA clone (derived from primary cultures of cystic fibro-
sis lung epithelial cells) [GenBank:BM982194] demon-
strate the existence of human full-length preproghrelin
transcripts with an extended exon 1, there has been no evi-
dence that this region is transcribed in the mouse. To ver-
ify the existence of the extended exon 1 we performed RT-
PCR experiments (Fig. 3). RT-PCRs, employing a sense
Partial genomic sequence of the murine ghrelin gene showing  exon 0 and extended exon 1 transcription start sites in a  number of tissues Figure 1
Partial genomic sequence of the murine ghrelin gene 
showing exon 0 and extended exon 1 transcription 
start sites in a number of tissues. Exon sequences are 
boxed and in upper case letters. The extended exon 1 
sequence is indicated by dashed boxes. Nucleotide positions 
are shown on the left and the translation initiation site of 
preproghrelin is indicated as +1. Intron 0 is highlighted in 
grey and its intron boundaries are shown in bold letters. Six 
transcription start sites (TSSs), denoted TSS1-6 (underlined 
and indicated), were demonstrated using an OriGene Sure-
RACE Multi-Tissue RACE panel. TSS1 initiates a 48 bp exon 
0 (exon 0b) [GenBank:FJ355944]; TSS2 [GenBank:FJ355945] 
initiates a 19 bp exon 0 (exon 0a); TSS3-6 (exon 1e-b, 
respectively) all initiate transcripts with an extended exon 1 
[GenBank: FJ355940–FJ355943]. The exon 0 CAGE tag start-
ing sites T06R06CF33DC, T06R06CF32CB and 
T06R06CF3202 are termed CAGE1-3, respectively.BMC Research Notes 2009, 2:85 http://www.biomedcentral.com/1756-0500/2/85
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primer in the extended exon 1 and an antisense primer in
exon 1, confirmed that exon 1 is transcribed and not a
result of genomic or exogenous contamination (Fig. 3B).
Next, we obtained an amplicon containing the extended
exon 1 to 4 in the liver and spleen [GenBank:FJ914266],
proving experimentally that the extended exon 1 can give
rise to full-length preproghrelin transcripts (Fig. 3C).
It was previously reported that the murine ghrelin gene
consists of five exons and a single transcription start site in
a short, 19 bp exon 0 [3]. Our results demonstrate that the
murine gene consists of at least two first exons (exon 0
and exon 1) (Fig. 4) with multiple transcription start sites
within each first exon region, which is typical of broad-
type promoters [8].
Ghrelin transcripts with an extended exon 1 are highly 
expressed in a limited number of tissues
We also investigated the distribution of extended exon 1-
containing Ghrl transcripts by transcript profiling in 36
normal mouse tissues. This analysis indicated that the
extended exon 1 species are predominantly expressed in
the spleen, adrenal gland, stomach, skin, adipose tissue,
and epididymis (Fig. 5). Interestingly, the human
extended exon 1 is also differentially expressed, with
equal levels of the 20 bp exon 0 and extended exon 1 in
the stomach [5]. In contrast, very high levels of the
extended exon 1 and almost undetectable levels of the 20
bp exon 0 have been reported in the human thyroid med-
ullary carcinoma TT cell line [5]. In both humans and
rodents, total ghrelin mRNA levels are very high in the
stomach, while much lower levels can be found in other
Comparison of mouse and human ghrelin exon 1 sequences showing exon 1 extended transcription start sites Figure 2
Comparison of mouse and human ghrelin exon 1 sequences showing exon 1 extended transcription start sites. 
The mouse and human alignments were generated by the ClustalW program and drawn by BOXSHADE http://
www.ch.embnet.org/software/BOX_form.html). Black shading indicates conserved nucleotides. Transcription start sites deter-
mined by 5' RACE (Δ), as well as a full-length cDNA clone [GenBank:BM982194] (*), are indicated, and the exact transcription 
start site nucleotides are shaded in grey in each species. Exon-intron boundaries are highlighted in red. The start codon of pre-
proghrelin is highlighted in yellow.BMC Research Notes 2009, 2:85 http://www.biomedcentral.com/1756-0500/2/85
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tissues, including the adrenal gland [9,10], suggesting that
the expression of the extended exon 1 may be develop-
mental-, cell- and tissue-specific.
A possible role for 5' variant exons of preproghrelin 
transcripts in translational control
As observed previously for exon 0 of the human ghrelin
gene [2], several very short upstream open reading frames
(uORFs) are present in the extended exon 1 and exon 0
sequence (data not shown). Upstream open reading
frames, mRNA secondary structure and other motifs in 5'
untranslated exons have been shown to regulate the trans-
lation of developmental genes [11]. Interestingly, it has
been reported that ghrelin mRNA and protein levels do
not directly correlate in the rat [12]. We hypothesise that
this may be caused by the transcription of different first
Ghrl exons with different preproghrelin translation effi-
ciencies. This mechanism is exemplified in the chicken
embryo where transcripts harbouring uORFs allow low-
level translation of proinsulin, whereas a higher level of
proinsulin expression is achieved in the adult pancreas by
transcription of mRNAs from a downstream first exon
devoid of uORFs [13]. Moreover, alternative 5' untrans-
lated exons can have an mRNA secondary structure that
restrains translation, particularly if a hairpin occurs close
to the 5' cap, which is the ribosomal entry site [14]. The
short 19 bp exon 0, which we and others [3] have
described, is devoid of upstream open reading frames or
stable secondary structure. This transcript, therefore,
could be more efficiently translated than the 233 bp 5'
extended exon 1 (exon 1e) that contains a 266 bp 5'
untranslated region, for example (see [Additional file 2]).
Conclusion
In this report, we demonstrate that transcription start sites
in exon 0 an extended exon 1 are present in the murine
ghrelin gene, suggesting that there are similarities in the
proximal first exon organisation of the murine ghrelin
gene and its human orthologue. A novel, extended exon 1
is expressed at high levels in the spleen, adrenal gland,
stomach, and skin, indicating that the murine ghrelin
gene harbours a cell-type, development-stage and/or tis-
sue-specific, proximal promoter in intron 0. Little is
known about the promoters of the murine ghrelin gene.
Only the role of rat ghrelin sequence, which is upstream
Verification of an extended exon 1 in the mouse ghrelin gene Figure 3
Verification of an extended exon 1 in the mouse 
ghrelin gene. A. Schematic diagram showing the structure 
of the murine ghrelin gene. Exons are represented as boxes 
and introns as horizontal lines. PCR primers employed in B. 
and C. are shown as arrows and the exon regions amplified 
are indicated. B. Ethidium bromide stained agarose gel elec-
trophoresis demonstrating Ghrl extended exon 1 to exon 1 
RT-PCR amplicons. DNase treated total RNA was amplified 
by RT-PCR with reverse transcriptase (+RT), or without (-
RT) reverse transcriptase to demonstrate that there was no 
genomic DNA contamination. Gapdh was used as an endog-
enous control. C. Ethidium bromide stained agarose gel elec-
trophoresis of a 445 bp full-length preproghrelin amplicon 
derived using primers located in the extended exon 1 (Ext1-
F) and exon 4 (Ex4-R). M = 100 bp DNA molecular weight 
marker ladder (New England Biolabs). NTC = no template 
negative control.
Comparison of the human and mouse ghrelin gene Figure 4
Comparison of the human and mouse ghrelin gene. 
The human ghrelin gene (GHRL) contains three first 5' 
untranslated exons (-1, 0 and a 5' extended exon 1/5'ext) 
shown as blue boxes. Note that the human exon -1 can also 
splice into exon 0. The murine ghrelin gene (Ghrl) contains 
exons homologous to the human exon 0 and the 5' extended 
exon 1 (shown as orange boxes), but lacks exon -1. The min-
imum and maximum size (in base pairs) of exons is shown 
above each exon.BMC Research Notes 2009, 2:85 http://www.biomedcentral.com/1756-0500/2/85
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of the 19 bp exon 0, has been investigated in promoter
constructs in murine cell-lines, and this demonstrated
minimal promoter activity [15]. The upstream, proximal




The murine ghrelin gene (Ghrl) architecture was examined
using the RIKEN Genomic Element Viewer provided by
the FANTOM (Functional Annotation of Mouse) consor-
tium [16]. This database includes transcripts within the
mouse genome as well as CAGE (Cap Analysis of Gene
Expression) tags corresponding to the 5' ends of tran-
scripts [16]. The location of ghrelin locus-derived ESTs
and mRNA entries, as well as sequenced PCR amplicons
obtained in this study, were identified by BLAST searches
against GenBank databases [17]. The minimum free ener-
gies (ΔG) of the 5' untranslated regions (5' UTRs) were
calculated using the RNAfold web server [18].
5' RACE
5' RACE was performed with primers specific for exon 1 of
Ghrl using a mouse Sure-RACE kit (OriGene) according to
the manufacturer's instructions. Samples of cDNAs from
24 murine tissues (brain, heart, kidney, spleen, thymus,
liver, stomach, small intestine, muscle, lung, testis, skin,
adrenal gland, salivary gland, uterus, prostate, embryonic
developmental stages (8–9-day, 9.5-day, 12-day and 19-
day post-conception), breast (immature, pregnant, lactat-
ing, involuting) were challenged. All tissues were from
NIH Swiss mice, except for the breast tissues that were
obtained from outbred CD-1 mice. An outer PCR was per-
formed for 25 cycles at 62°C with a 5' RACE adapter-spe-
cific forward primer and a Ghrl exon 1-specific reverse
primer (RACEout-F/R, Table 1). PCR products were then
diluted 1/100 and subjected to a nested PCR with adapter
and Ghrl exon 1 gene specific primers (RACEin-F/R, Table
1) at 61°C for 35 cycles. All PCRs were performed in a
total reaction volume of 50 μl using 1 U of Platinum Taq
Polymerase High Fidelity (Invitrogen) according to the
manufacturer's instructions. PCR products were purified
by ethanol purification, sub-cloned into pGEM-T Easy
(Promega) and sequenced by the Australian Genome
Research Facility (AGRF, Brisbane, Australia) using the
ABI PRISM BigDye Terminator Cycle Sequencing Kit v3.1
protocol (Applied Biosystems, AB, Foster City, CA).
Verification of extended exon 1 and cloning of full-length 
preproghrelin with an extended exon 1
2 μg DNase-treated total RNA from the liver, brain and
spleen of Swiss Webster mice (Ambion) was reverse tran-
scribed with 200 units of SuperScript III (Invitrogen)
using oligo(dT)20 primers in a final volume of 20 μl
according to the manufacturer's instructions. The result-
ing single-stranded cDNA was treated with ribonuclease H
(Invitrogen). PCRs were performed with a forward primer
in the extended exon 1 (Ext1-F, Table 1) and a reverse
primer in exon 1 (Ex1-R, Table 1) in a total reaction vol-
ume of 50 μl using 1 unit Platinum Taq Polymerase (Inv-
itrogen) according to the manufacturer's instructions.
RNA samples that were not reverse transcribed were run to
control for genomic DNA and a no template control
(water) was included to control for exogenous contamina-
tion. Cloning of full-length (exon 1 to 4) Ghrl transcripts
containing the extended exon 1 was achieved by PCRs
Real-time RT-PCR demonstrating tissue-specific expression of murine ghrelin transcripts with an extended exon 1 Figure 5
Real-time RT-PCR demonstrating tissue-specific expression of murine ghrelin transcripts with an extended 
exon 1. Relative expression of extended exon 1 of Ghrl in a wide range of mouse tissues (TissueScan Mouse Normal Tissue 
qPCR array). Calculations of Ghrl expression levels were performed using the standard curve method (correlating the thresh-
old cycle number (CT values) and copy numbers of Ghrl) and normalised to the expression of Gapdh.BMC Research Notes 2009, 2:85 http://www.biomedcentral.com/1756-0500/2/85
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using the same extended exon 1 primer (Ext1-F, Table 1)
and a primer in exon 4 (ex4-R, Table 1). PCR products
were purified and sequenced as described above.
Transcript Profiling in Mouse Tissues
Transcript profiling of murine Ghrl transcripts that con-
tain an extended exon 1 was performed by using a Tis-
sueScan Mouse Normal Tissue qPCR array (OriGene)
derived from both male and female NIH Swiss mice. The
samples in this array are generated by reverse transcription
of mouse poly(A)+ RNAs, which are free of genomic DNA,
using oligo(dT) primers. The array plates are loaded with
equal amounts of cDNA per well, as described by the
manufacturer (OriGene). Extended exon 1 transcript
expression levels were examined using 2× SYBR Green
PCR Master Mix (AB) and the primers Ext1-F/R (Table 1).
The amount of mRNA was determined by normalising the
levels of expression with the glyceraldehyde 3-phosphate
dehydrogenase (Gapdh) (Gapdh-F/R, Table 1) expression
in the tissues. Primers were designed using Primer Express
v.2.0 (AB) to yield a single amplicon, and were verified by
dissociation curve analysis. The quantitative real-time RT-
PCR conditions were optimised using purified PCR prod-
ucts. Real-time RT-PCR was performed using the 2× SYBR
green PCR master mix on the AB 7000 sequence detection
system and data analysed using the absolute standard
curve method (User Bulletin #2, AB) to determine expres-
sion levels.
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Additional file 1
Compilation of exons and exon-intron boundaries of the murine ghre-
lin gene. This is a PDF listing exons and intron boundaries of mouse ghre-
lin locus derived transcripts. Exon and intron sizes (bp) are indicated. 
Experimental evidence and/or references to the literature for each exon are 
shown. Note that exons 1b-e correspond to 5' extended exon 1 sequences.




Compilation of 5' UTR sequences of the murine ghrelin gene. Compi-
lation of 5' UTR sequences of the murine ghrelin gene (Ghrl) based on 5' 
RACE clones obtained in this study. The length (AA) of putative upstream 
open reading frames (uORF) corresponds to the distance from the start 
codon of preproghrelin to the transcription start site. The minimum free 
energies (ΔG) of the 5' UTRs were calculated using the RNAfold web 
server [18]. The more negative the minimum free energy an RNA struc-
ture has, the more secondary structure the RNA is likely to have.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
0500-2-85-S2.pdf]
Table 1: Designations and sequences of primers used in RT-PCR
Name Sequence (5'-3') Ghrl
Exon
Ta (°C) PCR Cycles
RACEout-F AATTCGTCACTCCGTGAATCAG N/A
RACEout-R CAGAGCATGCTGAGTAGCAG 1 62 25
RACEin-F GTCACTCCGTGAATCAGATCG N/A
RACEin-R CAGCAAACTGCAGATGGTG 1 61 35
Ext1-F AAGGCACATAACATGGAGATGAAG 1*
Ex1-R CTTGGTGGTGAGGACAGATGAC 1 60 40
Ex4-R GCCTGTCCGTGGTTACTTGT 4 58 40
Gapdh-F ACCTGCCAAGTATGATGACATCA N/A
Gapdh-R GGTCCTCAGTGTAGCCCAAGAT N/A 60 40
Annealing temperatures (Ta) of oligonucleotide primers employed in RT-PCR are shown. The location of oligonucleotide primers spanning ghrelin 
exons are listed, while oligonucleotides spanning synthetic sequences (adapters and linkers) or genes other than Ghrl are denoted as N/A (not 
applicable). The novel extended exon 1 is denoted as 1*. All primers were synthesised by Proligo (Armidale, Australia).Publish with BioMed Central    and   every 
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